Stock Buybacks (Quarterly) Chart

View Stock Buybacks (Quarterly) for FCHS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Stock Buybacks (Quarterly) Chart
Start Trial

Historical Stock Buybacks (Quarterly) Data

View and export this data back to 2007. Start Trial.
Date Value
June 30, 2026 0.00
March 31, 2026 0.00
December 31, 2025 0.00
September 30, 2025 0.00
June 30, 2025 0.00
March 31, 2025 0.00
December 31, 2024 0.00
September 30, 2024 0.00
June 30, 2024 0.00
March 31, 2024 0.00
December 31, 2023 -0.01M
September 30, 2023 0.01M
June 30, 2023 -0.045M
March 31, 2023 0.00
September 30, 2018 0.00
June 30, 2018 0.00
March 31, 2018 -7.50M
December 31, 2017 0.0621M
September 30, 2017 0.1372M
June 30, 2017 0.05M
March 31, 2017 0.00
December 31, 2016 0.60M
September 30, 2016 0.00
June 30, 2016 0.00
March 31, 2016 0.00
Date Value
December 31, 2015 -0.175M
September 30, 2015 0.00
June 30, 2015 0.00
March 31, 2015 0.00
December 31, 2014 0.00
September 30, 2014 0.00
June 30, 2014 0.00
March 31, 2014 0.00
December 31, 2013 0.00
September 30, 2013 0.00
June 30, 2013 0.00
March 31, 2013 0.00
December 31, 2012 0.00
September 30, 2012 0.00
June 30, 2012 0.00
March 31, 2012 0.00
December 31, 2011 0.00
September 30, 2011 0.00
June 30, 2011 0.00
March 31, 2011 0.00
December 31, 2010 0.00
September 30, 2010 0.00
June 30, 2010 0.00
March 31, 2010 0.00
December 31, 2009 -0.015M

Stock Buyback Definition

Stock buybacks are when companies buy back their own stock, removing it from the marketplace. Stock buybacks increase the value of the remaining shares because there is now less common stock outstanding and company earnings are split among fewer shares.

Read full definition.

Stock Buybacks (Quarterly) Range, Past 5 Years

View Stock Buybacks (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Stock Buybacks (Quarterly) Benchmarks

View Stock Buybacks (Quarterly) Benchmarks
Start Trial
Quest Diagnostics, Inc. 86.00M
Labcorp Holdings, Inc. 352.00M
OPKO Health, Inc. 13.36M
Psychemedics Corp. --
NeoGenomics, Inc. 21.64M